(Q33738699)

29 July 2017

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome (English)

1 reference

29 July 2017

Aaron L Carrel

1

1 reference

29 July 2017

Susan E Myers

2

1 reference

29 July 2017

Barbara Y Whitman

3

1 reference

29 July 2017

Jens Eickhoff

4

1 reference

29 July 2017

David B Allen

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

8 January 2010

1 reference

The Journal of Clinical Endocrinology and Metabolism

29 July 2017

1 reference

29 July 2017

95

1 reference

29 July 2017

3

1 reference

29 July 2017

1131-1136

1 reference

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Recommendations for the diagnosis and management of Prader-Willi syndrome

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Peculiar body composition in patients with Prader-Labhart-Willi syndrome

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Long-term safety of recombinant human growth hormone in children

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841537

About the benefits of growth hormone treatment in children with Prader-Willi syndrome

30 October 2018

1 reference

12 December 2020

Improving body composition and physical activity in Prader-Willi Syndrome

1 reference

12 December 2020

Growth hormone secretion in Prader-Willi syndrome

1 reference

12 December 2020

Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance

1 reference

12 December 2020

Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study

1 reference

12 December 2020

Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome

1 reference

12 December 2020

Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in c

1 reference

12 December 2020

Identifiers

DOI

10.1210/JC.2009-1389

1 reference

release_vqh52j4g4jctdctpmjbmynqkzi

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vqh52j4g4jctdctpmjbmynqkzi

24 November 2022

mapped directly with Wikidata item

PMCID

2841537

1 reference

29 July 2017

1 reference